Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: implications for viral immune escape.

Severa M, Giacomini E, Gafa V, Anastasiadou E, Rizzo F, Corazzari M, Romagnoli A, Trivedi P, Fimia GM, Coccia EM.

Eur J Immunol. 2013 Jan;43(1):147-58. doi: 10.1002/eji.201242552. Epub 2012 Oct 30.

2.

Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming.

Ogata M, Ito T, Shimamoto K, Nakanishi T, Satsutani N, Miyamoto R, Nomura S.

Int Immunol. 2013 Mar;25(3):171-82. doi: 10.1093/intimm/dxs103. Epub 2012 Nov 2.

PMID:
23125331
3.

TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells.

Fiola S, Gosselin D, Takada K, Gosselin J.

J Immunol. 2010 Sep 15;185(6):3620-31. doi: 10.4049/jimmunol.0903736. Epub 2010 Aug 16.

4.
5.

Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells.

Quan TE, Roman RM, Rudenga BJ, Holers VM, Craft JE.

Arthritis Rheum. 2010 Jun;62(6):1693-701. doi: 10.1002/art.27408.

6.

Hepatitis C virus fails to activate NF-κB signaling in plasmacytoid dendritic cells.

Dental C, Florentin J, Aouar B, Gondois-Rey F, Durantel D, Baumert TF, Nunes JA, Olive D, Hirsch I, Stranska R.

J Virol. 2012 Jan;86(2):1090-6. doi: 10.1128/JVI.05444-11. Epub 2011 Nov 16.

7.

Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.

Kuo CH, Hsieh CC, Kuo HF, Huang MY, Yang SN, Chen LC, Huang SK, Hung CH.

Allergy. 2013 Jul;68(7):870-9. doi: 10.1111/all.12162. Epub 2013 Jun 5.

8.

Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells.

Varani S, Cederarv M, Feld S, Tammik C, Frascaroli G, Landini MP, Söderberg-Nauclér C.

J Immunol. 2007 Dec 1;179(11):7767-76.

9.
10.

Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs.

Ito T, Amakawa R, Inaba M, Hori T, Ota M, Nakamura K, Takebayashi M, Miyaji M, Yoshimura T, Inaba K, Fukuhara S.

J Immunol. 2004 Apr 1;172(7):4253-9.

11.

A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.

Rajnavölgyi E, Nagy N, Thuresson B, Dosztányi Z, Simon A, Simon I, Karr RW, Ernberg I, Klein E, Falk KI.

Int Immunol. 2000 Mar;12(3):281-93.

PMID:
10700463
12.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
13.

BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.

Jähn PS, Zänker KS, Schmitz J, Dzionek A.

Cell Immunol. 2010;265(1):15-22. doi: 10.1016/j.cellimm.2010.06.005. Epub 2010 Jul 6.

PMID:
20673884
14.
15.

Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.

Cavalcante P, Galbardi B, Franzi S, Marcuzzo S, Barzago C, Bonanno S, Camera G, Maggi L, Kapetis D, Andreetta F, Biasiucci A, Motta T, Giardina C, Antozzi C, Baggi F, Mantegazza R, Bernasconi P.

Immunobiology. 2016 Apr;221(4):516-27. doi: 10.1016/j.imbio.2015.12.007. Epub 2015 Dec 12.

PMID:
26723518
16.

Induction of antiviral cytotoxic T cells by plasmacytoid dendritic cells for adoptive immunotherapy of posttransplant diseases.

Aspord C, Laurin D, Richard MJ, Vie H, Chaperot L, Plumas J.

Am J Transplant. 2011 Dec;11(12):2613-26. doi: 10.1111/j.1600-6143.2011.03722.x. Epub 2011 Aug 29.

17.

Immune activation suppresses initiation of lytic Epstein-Barr virus infection.

Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli FK, Speck RF, Nadal D.

Cell Microbiol. 2007 Aug;9(8):2055-69. Epub 2007 Apr 5.

PMID:
17419714
18.

Manipulation of immune responses by Epstein-Barr virus.

Levitsky V, Masucci MG.

Virus Res. 2002 Sep;88(1-2):71-86. Review.

PMID:
12297328
19.

Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.

Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T, Lee KD, Coffman RL, Barrat FJ.

J Exp Med. 2006 Aug 7;203(8):1999-2008. Epub 2006 Jul 24.

20.

Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells.

Colisson R, Barblu L, Gras C, Raynaud F, Hadj-Slimane R, Pique C, Hermine O, Lepelletier Y, Herbeuval JP.

Blood. 2010 Mar 18;115(11):2177-85. doi: 10.1182/blood-2009-06-224741. Epub 2009 Dec 10.

Supplemental Content

Support Center